R&D Offer

From the Identification of New Biological Targets to International Phase 3 Clinical Trials


CALYM offers a unique R&D approach in lymphoma diagnosis and treatment.
 

Consult CALYM researchers publications on https://hal.archives-ouvertes.fr/CALYM!


 

Contact us:+33 (0)4 72 24 41 71, by e-mail or by submitting your question in the contact form.